Elagolix reduces menstrual bleeding from most common uterine tumors
A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States—benign tumors that disproportionately affect African-Americans, an international clinical trial ...
Nov 9, 2018
0
0